Ibis Reproductive Health are pleased to invite you to hear experts discuss the results of the landmark, collaborative, study between Ibis Reproductive Health and safe abortion accompaniment groups GIWYN and La Revuelta—The Studying Accompaniment Feasibility & Effectiveness (SAFE) study, which were published in The Lancet Global Health. The SAFE study found that self-managed abortion (SMA) with medications and accompaniment group support was highly effective and safe.
Please see the invite below for details.
Register for the global perspectives webinar on Tuesday, December 7
Register for the US perspectives webinar on Wednesday, December 8
Also see the SAFE study website (interactive study findings, resources on SMA, and info about our partners) and SAFE study project page (fact sheet, briefs, and other relevant resources).